Comprehensive Psychiatry
Volume 46, Issue 4 , Pages 246-253 , July 2005

Mental health service use by patients with dysthymic disorder: treatment use and dropout in a 7 1/2-year naturalistic follow-up study

Received 16 June 2004 ,Accepted 7 October 2004.

References 

  1. Arnow BA, Constantino MJ. Effectiveness of psychotherapy and combination treatment for chronic depression. J. Clin. Psychol. 2003;59:893–905
  2. Kocsis JH. Pharmacotherapy for chronic depression. J. Clin. Psychol. 2003;59:885–892
  3. Markowitz JC. Interpersonal psychotherapy for chronic depression. J. Clin. Psychol. 2003;59:847–858
  4. Kessler RC, Olfson M, Berglund PA. Patterns and predictors of treatment contact after first onset of psychiatric disorders. Am. J. Psychiatry. 1998;155:62–69
  5. Kessler RC, Zhao S, Katz SJ, Kouzis AC, Frank RG, Edlund M, et al. Past-year use of outpatient services for psychiatric problems in the National Comorbidity Survey. Am. J. Psychiatry. 1999;156:115–123
  6. Narrow WE, Regier DA, Rae DS, Manderscheid RW, Locke BZ. Use of services by persons with mental and addictive disorders: findings from the National Institute of Mental Health Epidemiologic Catchment Area Program. Arch. Gen. Psychiatry. 1993;50:95–107
  7. Regier DA, Narrow WE, Rae DS, Manderscheid RW, Locke BZ, Goodwin FK. The de facto US Mental and Addictive Disorders Service System: epidemiologic catchment area prospective 1-year prevalence rates of disorders and services. Arch. Gen. Psychiatry. 1993;50:85–94
  8. Ware JE, Manning WG, Duan N, Wells KB, Newhouse JP. Health status and the use of outpatient mental health service. Am. Psychol. 1984;39:1090–1100
  9. Hellerstein DJ, Yanowitch P, Rosenthal J, Samstag LW, Maurer M, Kasch K, et al. A randomized double-blind study of fluoxetine versus placebo in the treatment of dysthymia. Am. J. Psychiatry. 1993;150:1169–1175
  10. Ravindran AV, Anisman H, Merali Z, Charbonneau Y, Telner J, Bialik RJ, et al. Treatment of primary dysthymia with group cognitive therapy and pharmacotherapy: clinical symptoms and functional impairments. Am. J. Psychiatry. 1999;156:1608–1617
  11. de Mello MF, Myczkowisk LM, Menezes PR. A randomized controlled trial comparing moclobemide and moclobemide plus interpersonal psychotherapy in the treatment of dysthymic disorder. J. Psychother. Pract. Res. 2001;10:117–123
  12. Browne G, Steiner M, Roberts J, Gafni A, Byrne C, Dunn E, et al. Sertraline and/or interpersonal psychotherapy for patients with dysthymic disorder in primary care: 6-month comparison with longitudinal 2-year follow-up of effectiveness and costs. J. Affect. Disord. 2002;68:317–330
  13. Kocsis JH, Zisook S, Davidson J, Shelton R, Yonkers K, Hellerstein DJ, et al. Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: psychosocial outcomes. Am. J. Psychiatry. 1997;154:390–395
  14. Levitt AJ, Joffe RT, Sokolov STH. Does the chronological relationship between the onset of dysthymia and major depression influence subsequent response to antidepressants?. J. Affect. Disord. 1998;47:169–175
  15. Lenze EJ, Miller MD, Dew MA, Martire LM, Mulsant BH, Begley AE, et al. Subjective health measures and acute treatment outcomes in geriatric depression. Int. J. Geriatr. Psychiatry. 2001;16:1149–1155
  16. Lawrenson RA, Tyrer F, Newson RB, Farmer RDT. The treatment of depression in UK general practice: selective serotonin reuptake inhibitors and tricyclic antidepressants compared. J. Affect. Disord. 2000;59:149–157
  17. Cuijpers P. Psychological outreach programmes for the depressed elderly: a meta-analysis of effects and dropout. Int. J. Geriatr. Psychiatry. 1998;13:41–48
  18. Herceg-Baron RL. Pharmacotherapy and psychotherapy in acutely depressed patients: a study of attrition patterns in a clinical trial. Compr. Psychiatry. 1979;20:315–325
  19. de Jonghe F, Kool S, van Aalst G, Dekker J, Peen J. Combining psychotherapy and antidepressants in the treatment of depression. J. Affect. Disord. 2001;64:217–229
  20. Meresman JF, Horowitz LM, Bein E. Treatment assignment, dropout, and outcome of depressed patients who somaticize. Psychother. Res. 1995;5:245–257
  21. Blackburn IM, Bishop S, Glen AI, Whalley LJ, Christie JE. The efficacy of cognitive therapy in depression: a treatment trial using cognitive therapy and pharmacotherapy, each alone and in combination. Br. J. Psychiatry. 1981;139:181–189
  22. Deykin EY, DiMascio A. Relationship of patient background characteristics to efficacy of pharmacotherapy in depression. J. Nerv. Ment. Dis. 1972;155:209–215
  23. Last CG, Thase ME, Hersen M, Bellack AS, Himmelhoch JM. Patterns of attrition for psychosocial and pharmacologic treatments of depression. J. Clin. Psychiatry. 1985;46:361–366
  24. Oei TP, Kazmierczak T. Factors associated with dropout in a group cognitive behaviour therapy for mood disorders. Behav. Res. Ther. 1997;35:1025–1030
  25. Simons AD, Levine JL, Lustman PJ, Murphy GE. Patient attrition in a comparative outcome study of depression. J. Affect. Disord. 1984;6:163–173
  26. Persons JB, Burns DD, Perloff JM. Predictors of dropout and outcome in cognitive therapy for depression in a private practice setting. Cogn. Ther. Res. 1998;12:557–575
  27. Demyttenaere K, Van Ganse E, Gregoire J, Gaens E, Mesters P. Compliance in depressed patients treated with fluoxetine or amitriptyline. Int. Clin. Psychopharmacol. 1998;13:11–17
  28. Gilbert M, Fine S, Haley G. Factors associated with dropout from group psychotherapy with depressed adolescents. Can. J. Psychiatry. 1994;39:358–359
  29. Tedlow JR, Maurizio F, Uebelacker LA, Alpert JE, Nierenberg AA, Rosenbaum FF. Are study dropouts different from completers?. Biol. Psychiatry. 1996;40:668–670
  30. Hoencamp E, Haffmans PMJ, Duivenvoorden HJ. Predictability of dropout in unipolar depressed outpatients. Eur. Psychiatry. 1998;13:63–66
  31. Keller MB, McCullough JP, Klein DN, Arnow B, Dunner DL, Gelenberg AJ, et al. A comparison of nefazodone, the Cognitive Behavioral Analysis System of Psychotherapy, and their combination for the treatment of chronic depression. N. Engl. J. Med. 2000;342:1462–1470
  32. McLean PD, Hakstian AR. Clinical depression: comparative efficacy of outpatient treatments. J. Consult. Clin. Psychol. 1979;47:818–836
  33. Klein DN, Riso LP, Donaldson SK, Schwartz JE, Anderson RL, Ouimette PC, et al. Family study of early-onset dysthymia: mood and personality disorders in relatives of outpatients with dysthymia and episodic major depression and normal controls. Arch. Gen. Psychiatry. 1995;52:487–496
  34. Klein DN, Norden KA, Ferro T, Leader JB, Kasch KL, Klein LM, et al. Thirty-month naturalistic follow-up study of early-onset dysthymic disorder: course, diagnostic stability, and prediction of outcome. J. Abnorm. Psychol. 1998;107:338–348
  35. Klein DN, Schwartz JE, Rose S, Leader JB. Five-year course and outcome of dysthymic disorder: a prospective, naturalistic follow-up study. Am. J. Psychiatry. 2000;157:931–939
  36. Spitzer RL, Williams JBW, Gibbon M, First MB. Structured clinical interview for DSM-III-R (SCID). Washington (DC): American Psychiatric Press; 1990;
  37. Miller IW, Bishop S, Norman WH, Maddever H. The Modified Hamilton Rating Scale for depression: reliability and validity. Psychiatry Res. 1985;14:131–142
  38. Beck AT, Weissman A, Lester D, Trexler L. The measurement of pessimism: the Hopelessness Scale. J. Consult. Clin. Psychol. 1974;42:861–865
  39. Loranger AW. The personality disorder examination manual. Yonkers (NY): DV Communications; 1998;
  40. Akiskal HS. Dysthymic disorder: psychopathology of proposed chronic depressive subtypes. Am. J. Psychiatry. 1983;140:11–20
  41. Schneider K. Psychopathic personalities. London (England): Cassell; 1958;
  42. Eysenck SBG, Eysenck HJ, Barrett P. A revised version of the psychoticism scale. Pers. Individ. Differ. 1985;6:21–29
  43. Robins CJ, Ladd J, Welkowitz J, Blaney PH, Diaz R, Kutcher G. The Personality Style Inventory: preliminary validation studies of a new measure of sociotropy and autonomy. J. Psychopathol. Behav. Assess. 1994;16:277–300
  44. Welkowitz J, Lish JP, Bond RN. The Depressive Experiences Questionnaire: revision and validation. J. Pers. Assess. 1985;49:89–94
  45. Keller MB, Lavori PW, Friedman B, Nielsen E, Endicott J, McDonald-Scott P, et al. The Longitudinal Interval Follow-up Evaluation: a comprehensive method for assessing outcome in longitudinal studies. Arch. Gen. Psychiatry. 1987;44:540–548
  46. Cohen S, Mermelstein R, Kamarck T, Hoberman H. Measuring the functional components of social support. In:  Sarasan IB,  Sarasan BR editor. Social support: theory, research, and applications. Dordrecht (The Nethelands): Martinus Nijhoff; 1985;p. 73–94
  47. Brown GW, Harris TO. Social origins of depression: a study of psychiatric disorders in women. London (UK): Tavistock; 1978;
  48. Lizardi H, Klein DN, Ouimette PC, Riso LP, Anderson RL, Donaldson SK. Reports of the childhood home environment in early-onset dysthymia and episodic major depression. J. Abnorm. Psychol. 1995;104:132–139
  49. Riso LP, Klein DN, Anderson RL, Ouimette PC, Lizardi H. Concordance between patients and informants on the Personality Disorder Examination. Am. J. Psychiatry. 1994;151:568–573
  50. Klein DN. Patients' versus informants' reports of personality disorders in predicting 7 ½-year outcome in outpatients with depressive disorders. Psychol. Assess. 2003;15:216–222
  51. Hellerstein DJ, Little SA, Samstag LW, Batchelder S, Muran JC, Fedak M, et al. Adding group psychotherapy to medication treatment in dysthymia: a randomized prospective pilot study. J. Psychother. Pract. Res. 2001;10:93–103

PII: S0010-440X(04)00157-9

doi: 10.1016/j.comppsych.2004.10.002

Comprehensive Psychiatry
Volume 46, Issue 4 , Pages 246-253 , July 2005

Article Tools